Nordea Investment Management Ab Sangamo Therapeutics, Inc Transaction History

Nordea Investment Management Ab

$92.4 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$1.66 - $3.67 $54,866 - $121,300	-33,052 Reduced 4.91%	640,346 $1.13 Million
Q4 2022 Feb 08, 2023	SELL	$2.77 - $5.07 $24,137 - $44,179	-8,714 Reduced 1.28%	673,398 $2.11 Million
Q3 2022 Oct 19, 2022	BUY	$4.27 - $6.39 $4,270 - $6,390	1,000 Added 0.15%	682,112 $3.43 Million
Q2 2022 Aug 09, 2022	BUY	$3.28 - $6.21 $107,196 - $202,955	32,682 Added 5.04%	681,112 $2.74 Million
Q1 2022 Apr 11, 2022	BUY	$5.23 - $7.82 $172,527 - $257,966	32,988 Added 5.36%	648,430 $3.94 Million
Q4 2021 Jan 20, 2022	SELL	$7.29 - $10.97 $80,583 - $121,262	-11,054 Reduced 1.76%	615,442 $4.84 Million
Q3 2021 Nov 01, 2021	SELL	$9.01 - $12.01 $5.64 Million - $7.52 Million	-626,496 Reduced 50.0%	626,496 $5.84 Million
Q3 2021 Nov 01, 2021	BUY	$9.01 - $12.01 $5.54 Million - $7.39 Million	615,102 Added 96.43%	1,252,992 $11.3 Million
Q2 2021 Jul 16, 2021	BUY	$10.17 - $12.64 $587,032 - $729,606	57,722 Added 9.95%	637,890 $7.64 Million
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $213,030 - $333,839	19,580 Added 3.49%	580,168 $7.16 Million
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $2.11 Million - $4.15 Million	228,077 Added 68.59%	560,588 $8.75 Million
Q3 2020 Nov 09, 2020	SELL	$9.38 - $12.48 $3.07 Million - $4.09 Million	-327,537 Reduced 49.62%	332,511 $3.28 Million
Q2 2020 Aug 13, 2020	BUY	$6.21 - $11.83 $2.08 Million - $3.97 Million	335,542 Added 103.4%	660,048 $5.91 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $37,895 - $66,410	7,504 Added 2.37%	324,506 $2.11 Million
Q4 2019 Feb 11, 2020	BUY	$8.03 - $11.7 $133,370 - $194,325	16,609 Added 5.53%	317,002 $2.63 Million
Q3 2019 Nov 13, 2019	BUY	$9.05 - $12.22 $19,240 - $25,979	2,126 Added 0.71%	300,393 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $91,437 - $136,163	-10,450 Reduced 3.38%	298,267 $3.21 Million
Q1 2019 May 20, 2019	SELL	$7.72 - $12.81 $53,808 - $89,285	-6,970 Reduced 2.21%	308,717 $2.95 Million
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $21,226 - $37,051	-2,232 Reduced 0.7%	315,687 $3.63 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $1.64 Million - $2.4 Million	125,903 Added 65.57%	317,919 $5.39 Million
Q2 2018 Aug 13, 2018	BUY	$13.9 - $19.8 $996,949 - $1.42 Million	71,723 Added 59.62%	192,016 $2.73 Million
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $2.01 Million - $3.17 Million	120,293 New	120,293 $2.29 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.4 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.58 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.41 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.71 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account